Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLGX
1051
DELISTED
Corelogic, Inc.
CLGX
| $6.91M | 0.02% |
227,588
-373,849
| -62% | -$10.8M |
|
1052
News Corp Class B
NWS
$17.7B
| $6.91M | 0.02% |
395,700
-106,300
| -21% | -$1.79M |
|
1053
Boston Scientific
BSX
$74.9B
| $6.9M | 0.02% |
540,205
-954,200
| -64% | -$12.4M |
|
|
PRGX
1054
DELISTED
PRGX Global, Inc.
PRGX
| $6.9M | 0.02% |
1,079,300
+17,840
| +2% | +$115K |
|
1055
Tower Semiconductor
TSEM
$28.6B
| $6.86M | 0.02% |
755,151
+286,140
| +61% | +$2.55M |
|
1056
Kilroy Realty
KRC
$4.22B
| $6.84M | 0.02% |
+109,900
| New | +$6.64M |
|
|
EDE
1057
DELISTED
Empire District Electric
EDE
| $6.83M | 0.02% |
266,000
+86,100
| +48% | +$2.08M |
|
|
EGL
1058
DELISTED
Engility Holdings, Inc.
EGL
| $6.83M | 0.02% |
178,500
-120,547
| -40% | -$4.99M |
|
|
CBM
1059
DELISTED
Cambrex Corporation
CBM
| $6.79M | 0.02% |
328,200
-142,325
| -30% | -$2.89M |
|
|
PRA
1060
DELISTED
ProAssurance
PRA
| $6.78M | 0.02% |
152,600
-79,404
| -34% | -$3.55M |
|
1061
Embotelladora Andina Series B
AKO.B
$4.89B
| $6.76M | 0.02% |
298,746
-25,554
| -8% | -$608K |
|
1062
TriCo Bancshares
TCBK
$1.84B
| $6.75M | 0.02% |
291,900
+25,663
| +10% | +$609K |
|
1063
Elbit Systems
ESLT
$36.5B
| $6.72M | 0.02% |
109,200
-2,600
| -2% | -$159K |
|
|
RDC
1064
DELISTED
Rowan Companies Plc
RDC
| $6.69M | 0.02% |
209,400
+106,600
| +104% | +$3.34M |
|
|
AAIC
1065
DELISTED
Arlington Asset Investment Corp.
AAIC
| $6.68M | 0.02% |
244,592
+38,275
| +19% | +$1.03M |
|
1066
Insperity
NSP
$1.92B
| $6.68M | 0.02% |
405,000
+68,400
| +20% | +$1.09M |
|
|
ITC
1067
DELISTED
ITC HOLDINGS CORP
ITC
| $6.67M | 0.02% |
+182,800
| New | +$6.75M |
|
|
WPRT
1068
Westport Fuel Systems
WPRT
$34.6M
| $6.67M | 0.02% |
37,000
-7,850
| -18% | -$1.17M |
|
|
CIR
1069
DELISTED
CIRCOR International, Inc
CIR
| $6.67M | 0.02% |
+86,423
| New | +$6.68M |
|
1070
Northwest Bancshares
NWBI
$2.31B
| $6.66M | 0.02% |
490,554
-205,900
| -30% | -$2.83M |
|
1071
Insulet
PODD
$10.1B
| $6.63M | 0.02% |
167,200
-197,700
| -54% | -$7.6M |
|
|
SVA
1072
DELISTED
Sinovac Biotech, Ltd
SVA
| $6.63M | 0.02% |
1,175,000
+143,289
| +14% | +$870K |
|
1073
Kemper
KMPR
$1.56B
| $6.6M | 0.02% |
179,000
+35,369
| +25% | +$1.31M |
|
1074
Clearfield
CLFD
$395M
| $6.58M | 0.02% |
392,199
-43,000
| -10% | -$783K |
|
1075
Prologis
PLD
$134B
| $6.57M | 0.02% |
+159,771
| New | +$6.57M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.